STOCK TITAN
  1. Home
  2. Sec-filings
  3. VICR
  4. [144] VICOR CORP SEC Filing

VICR (NASDAQ: VICR) director sells multiple blocks under 10b5-1 plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

VICR reported multiple scheduled disposals of common stock by Patrizio Vincarelli under 10b5-1 plans. The excerpt lists numerous 10b5-1 sales of 20,000 shares on many dates in June 2026 and larger 10b5-1 blocks in April 2026, with individual proceeds shown for each trade.

Positive

  • None.

Negative

  • None.

Insights

Routine, pre-arranged insider sales under written trading plans.

The excerpt shows repeated 10b5-1 sales executed by Patrizio Vincarelli, including multiple 20,000-share disposals in June 2026 and larger blocks in April 2026. These entries are listed with per-trade proceeds and dates, indicating systematic plan-based dispositions.

Cash-flow treatment is explicit per trade (proceeds listed alongside each sale). Timing and amounts are tied to the plan executions; any broader ownership or remaining position is not shown in the excerpt.

Representative trade size 20,000 shares multiple 10b5-1 sales in June 2026
April block - 04/16/2026 40,000 shares 10b5-1 sale listed on 04/16/2026
April block - 04/15/2026 50,000 shares 10b5-1 sale listed on 04/15/2026
Example proceeds - 06/30/2026 $7,500,833.00 gross proceeds shown for 20,000-share sale on 06/30/2026
Institutional entry - 05/14/2026 3,500 shares Brigham and Women's Hospital sale on 05/14/2026
10b5-1 regulatory
"10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Form 144 regulatory
"144: Securities Sold During The Past 3 Months"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Founders Shares financial
"Common | 11/10/1981 | Founders Shares"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

FAQ

Who sold shares in the VICR Form 144 filing?

The filing shows Patrizio Vincarelli as the primary seller. The excerpt lists numerous 10b5-1 sales by Vincarelli, with multiple 20,000-share transactions in June 2026 and larger blocks in April 2026.

Were the sales reported in the VICR excerpt part of a trading plan?

Yes. The transactions are described as 10b5-1 sales, indicating they were executed under pre-arranged trading plans. Each sale entry includes date, share count, and gross proceeds for that trade.

How large were the representative trades listed for VICR?

Representative entries include repeated 20,000-share sales in June 2026 and April 2026 blocks of 40,000 and 50,000 shares, each trade showing the gross proceeds beside the date and share count.

Does the excerpt state who received the proceeds from these VICR sales?

The excerpt lists gross proceeds per transaction next to each sale. It does not otherwise reassign proceeds; the per-trade proceeds are shown as the monetary amounts tied to the reported dispositions.

Are other holders or institutions named in the VICR excerpt?

Yes. The excerpt also lists institutional entries such as Brigham and Women's Hospital and Lahey Hospital & Medical Center with 3,500-share entries on 05/14/2026, each accompanied by a proceeds amount.